PreActiv Raises over £500,000 to Revolutionise Pre-Operative Care, Saving Healthcare Providers Millions
PreActiv, an innovative prehabilitation platform, is making waves in the healthtech industry, raising over £500,000 to revolutionise preoperative care. With a mission to slash patient complications, reduce bed days, and save healthcare providers millions, they are rapidly reshaping surgical care.
Prehabilitation has quickly evolved into a healthcare essential virtually overnight. Similar to rehabilitation but conducted before surgery, prehabilitation focuses on improving a patient’s cardiovascular fitness and strength, while also providing nutrition, lifestyle and psychological support to prepare them for their upcoming surgery. It reduces the risk of complications by 50 percent and shortens hospital stays by an average of two days, alongside improving a patient’s overall long term health.
Given these benefits it is unsurprising that NHS England has mandated trusts to incorporate prehabilitation into their care protocols as part of their new perioperative guidelines. As a result, healthcare providers are now actively seeking out cost-effective solutions that can be implemented on a large scale to meet this demand.
At the forefront of prehabilitation innovation is PreActiv. Founded by NHS doctors in 2020 the platform harnesses cutting-edge technology to create individualised prehabilitation programmes tailored to each patient’s needs. As a highly cost-effective prehabilitation option, they have become the ideal solution to meet NHS England’s latest guidelines.
PreActiv’s groundbreaking platform has garnered impressive interest, securing Exceptional Ventures as the lead investor. Exceptional Ventures, a VC firm focused on health and wellness investments, is enthusiastic about supporting PreActiv’s innovative approach and promising potential.
Exceptional Ventures Investment Manager, Michella Botto added: “We are thrilled to partner with Rebecca and Alec on PreActiv’s journey to revolutionise the prehabilitation space. Their scalable, evidence-based programmes significantly reduce surgical complications and accelerate recovery, offering a cost-effective solution to the £14 billion burden on the NHS. PreActiv’s integration of patient data, support networks, and educational resources makes it a promising innovation in improving surgical outcomes and long-term health.”
Joining Exceptional Ventures with follow-on funding is Europe’s leading early stage tech for good VC, Bethnal Green Ventures alongside Angel Academe and a group of experienced angel investors.
PreActiv co-founder Dr. Alec Snow, a consultant anaesthetist and ICU physician, said, “We are excited by the success of our pre-seed raise. Our goal within the next year is to become the market leads in prehabilitation, supplying healthcare providers with the tools they need to optimise patient health whilst reducing costs and pressure on their services”
Alongside closing their pre-seed investment round, the award winning company is also in the final weeks of their clinical trial, in collaboration with Bath University and Royal United Hospitals Bath.
Co-founder and Women in Innovation winner, Dr Rebecca Allam added: “PreActiv’s platform is already demonstrating transformative results. All users fitness has improved within six weeks by an average of 25.9 percent and adherence to all sessions prescribed is a staggering 99.6 percent with 88.4 percent of patients completing three sessions within seven days. This preliminary data showcases the power of individualised digital prehabilitation. We look forward to releasing the final clinical data within the coming months.”
— ENDS —
About PreActiv
An innovative digital platform that harnesses technology to create dynamic, individualised prehabilitation programmes to physically optimise patients for surgery. PreActiv optimises patients by improving their cardiovascular fitness and strength, and provides nutrition, lifestyle and psychological support. By embracing technology it reduces the reliance on healthcare professional time and so is a realistic method to meet recent NHS England guidance on patient optimisation.
About Exceptional Ventures
Exceptional Ventures is an early-stage Venture Capital firm based in London that invests in high-impact businesses focused on helping people live happier, healthier, and longer lives, while championing a sustainable planet. With its debut £12 million fund, Exceptional Ventures is building a portfolio of 40 early-stage startups primarily in the UK/EU and opportunistically across the rest of the world in the HealthTech, FoodTech, and Financial Health sectors.
About Bethnal Green Ventures
Bethnal Green Ventures (BGV) is Europe’s leading early-stage tech for good VC. They back ambitious founders from all walks of life using technology to tackle the world’s pressing social and environmental challenges aiming to positively impact millions of lives. PreActiv is a BGV accelerator programme alumni.
About Angel Academe
Angel Academe is an award-winning angel network who invest in female founded tech startups. Since 2014, their members have invested in over 45 early stage businesses. For more details on their portfolio see: https://www.angelacademe.com/portfolio
About Women in Innovation
Women in Innovation is part of Innovate UK’s commitment to promote greater diversity and inclusion in business innovation. Each year, the programme identifies women with innovative, high-potential ideas and ambitious plans that will inspire others. The programme is open to women founders, co-founders or senior decision makers working in businesses that have been operating for at least one year. The award winners each receive a £50,000 grant and a bespoke package of mentoring, coaching and business support. For more details see: https://ktn-uk.org/programme/women-in-innovation/
